Transgenic Expression of Nrf2 Induces a Pro-Reductive Stress and Adaptive Cardiac Remodeling in the Mouse

被引:10
作者
Jyothidasan, Arun [1 ]
Sunny, Sini [1 ]
Murugesan, Saravanakumar [2 ]
Quiles, Justin M. [3 ]
Challa, Anil Kumar [4 ]
Dalley, Brian [5 ]
Cinghu, Senthil Kumar [6 ]
Nanda, Vivek [1 ]
Rajasekaran, Namakkal-Soorappan [1 ,7 ,8 ]
机构
[1] Univ Alabama Birmingham, Dept Pathol, Mol & Cellular Pathol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Div Mol & Translat Biomed, Birmingham, AL 35294 USA
[3] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmacol, San Diego, CA 92093 USA
[4] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA
[5] Univ Utah, Huntsman Canc Ctr Genom Core Facil, Salt Lake City, UT 84112 USA
[6] NIEHS, Epigenet & Stem Cell Biol Lab, NIH, Res Triangle Pk, NC 27709 USA
[7] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84132 USA
[8] Univ Alabama Birmingham, Ctr Free Rad Biol CFRB, Birmingham, AL 35294 USA
关键词
Nrf2; transgene; constitutively active Nrf2; RNAseq; echocardiography; reductive stress; OXIDATIVE STRESS; PATHWAYS; IDENTIFICATION; ACTIVATION; INDUCTION; AUTOPHAGY; KEAP1; NOGO;
D O I
10.3390/genes13091514
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Nuclear factor, erythroid 2 like 2 (Nfe2l2 or Nrf2), is a transcription factor that protects cells by maintaining a homeostatic redox state during stress. The constitutive expression of Nrf2 (CaNrf2-TG) was previously shown to be pathological to the heart over time. We tested a hypothesis that the cardiac-specific expression of full length Nrf2 (mNrf2-TG) would moderately increase the basal antioxidant defense, triggering a pro-reductive environment leading to adaptive cardiac remodeling. Transgenic and non-transgenic (NTG) mice at 7-8 months of age were used to analyze the myocardial transcriptome, structure, and function. Next generation sequencing (NGS) for RNA profiling and qPCR-based validation of the NGS data, myocardial redox levels, and imaging (echocardiography) were performed. Transcriptomic analysis revealed that out of 14,665 identified mRNAs, 680 were differently expressed (DEG) in TG hearts. Of 680 DEGs, 429 were upregulated and 251 were downregulated significantly (FC > 2.0, p < 0.05). Gene set enrichment analysis revealed that the top altered pathways were (a) Nrf2 signaling, (b) glutathione metabolism and (c) ROS scavenging. A comparative analysis of the glutathione redox state in the hearts demonstrated significant differences between pro-reductive vs. hyper-reductive conditions (233 +/- 36.7 and 380 +/- 68.7 vs. 139 +/- 8.6 mu M/mg protein in mNrf2-TG and CaNrf2-TG vs. NTG). Genes involved in fetal development, hypertrophy, cytoskeletal rearrangement, histone deacetylases (HDACs), and GATA transcription factors were moderately increased in mNrf2-TG compared to CaNrf2-TG. Non-invasive echocardiography analysis revealed an increase in systolic function (ejection fraction) in mNrf2-TG, suggesting an adaptation, as opposed to pathological remodeling in CaNrf2-TG mice experiencing a hyper-reductive stress, leading to reduced survival (40% at 60 weeks). The effects of excess Nrf2-driven antioxidant transcriptome revealed a pro-reductive condition in the myocardium leading to an adaptive cardiac remodeling. While pre-conditioning the myocardial redox with excess antioxidants (i.e., pro-reductive state) could be beneficial against oxidative stress, a chronic pro-reductive environment in the myocardium might transition the adaptation to pathological remodeling.
引用
收藏
页数:14
相关论文
共 41 条
[1]   Nrf2 signaling pathway: Pivotal roles in inflammation [J].
Ahmed, Syed Minhaj Uddin ;
Luo, Lin ;
Namani, Akhileshwar ;
Wang, Xiu Jun ;
Tang, Xiuwen .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (02) :585-597
[2]   Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene [J].
Alam, J ;
Stewart, D ;
Touchard, C ;
Boinapally, S ;
Choi, AMK ;
Cook, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (37) :26071-26078
[3]   Accelerated DNA adduct formation in the lung of the Nrf2 knockout mouse exposed to diesel exhaust [J].
Aoki, Y ;
Sato, H ;
Nishimura, N ;
Takahashi, S ;
Itoh, K ;
Yamamoto, M .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2001, 173 (03) :154-160
[4]   Reductive Stress Linked to Small HSPs, G6PD, and Nrf2 Pathways in Heart Disease [J].
Brewer, Alison C. ;
Mustafi, Soumyajit Banerjee ;
Murray, Thomas V. A. ;
Rajasekaran, Namakkal Soorappan ;
Benjamin, Ivor J. .
ANTIOXIDANTS & REDOX SIGNALING, 2013, 18 (09) :1114-1127
[5]   Identification of Nogo as a novel indicator of heart failure [J].
Bullard, Tara A. ;
Protack, Tricia L. ;
Aguilar, Frederick ;
Bagwe, Suveer ;
Massey, H. Tood ;
Blaxall, Burns C. .
PHYSIOLOGICAL GENOMICS, 2008, 32 (02) :182-189
[6]   Hypertrophic effects of urocortin homologous peptides are mediated via activation of the Akt pathway [J].
Chanalaris, A ;
Lawrence, KM ;
Townsend, PA ;
Davidson, S ;
Jashmidi, Y ;
Stephanou, A ;
Knight, RD ;
Hsu, SY ;
Hsueh, AJW ;
Latchman, DS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (02) :442-448
[7]   Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy [J].
Depre, C ;
Shipley, GL ;
Chen, WH ;
Han, QY ;
Doenst, T ;
Moore, ML ;
Stepkowski, S ;
Davies, PJA ;
Taegtmeyer, H .
NATURE MEDICINE, 1998, 4 (11) :1269-1275
[8]   High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes [J].
Enomoto, A ;
Itoh, K ;
Nagayoshi, E ;
Haruta, J ;
Kimura, T ;
O'Connor, T ;
Harada, T ;
Yamamoto, M .
TOXICOLOGICAL SCIENCES, 2001, 59 (01) :169-177
[9]   Genetic Ablation of Nrf2/Antioxidant Response Pathway in Alexander Disease Mice Reduces Hippocampal Gliosis but Does Not Impact Survival [J].
Hagemann, Tracy L. ;
Jobe, Emily M. ;
Messing, Albee .
PLOS ONE, 2012, 7 (05)
[10]   An Nrf2 small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements [J].
Itoh, K ;
Chiba, T ;
Takahashi, S ;
Ishii, T ;
Igarashi, K ;
Katoh, Y ;
Oyake, T ;
Hayashi, N ;
Satoh, K ;
Hatayama, I ;
Yamamoto, M ;
Nabeshima, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 236 (02) :313-322